Apollomics, Inc.
APLM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $0 | $0 |
| % Growth | -75.9% | 154.2% | 16,050% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $1 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $25 | $34 | $35 | $36 |
| G&A Expenses | $18 | $21 | $10 | $15 |
| SG&A Expenses | $18 | $21 | $10 | $15 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $42 | $55 | $45 | $51 |
| Operating Income | -$42 | -$54 | -$45 | -$51 |
| % Margin | -21,280.8% | -6,578.9% | -13,957% | -2,542,850% |
| Other Income/Exp. Net | -$11 | -$119 | -$196 | -$44 |
| Pre-Tax Income | -$54 | -$173 | -$241 | -$95 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$54 | -$173 | -$241 | -$95 |
| % Margin | -27,201% | -21,023.3% | -74,554.5% | -4,739,850% |
| EPS | -52.8 | -231.99 | -61.6 | -23.45 |
| % Growth | 77.2% | -276.6% | -162.7% | – |
| EPS Diluted | -52.8 | -231.99 | -61.6 | -23.45 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$41 | -$53 | -$44 | -$50 |
| % Margin | -20,734.8% | -6,509.9% | -13,586.1% | -2,505,850% |